Cerebral Vasospasm Market to Grow at a CAGR of 5.4% through 2023 with most Prominent Players like Headsense Medical Ltd, B. Braun Melsungen AG, Minnetronix, Inc, Bristol-Myers Squibb Company and more

Worldwide Trend in “Cerebral Vasospasm Market” Completed Study on MarketResearchFuture.com, This Report Aim is Detail Analysis of Global Cerebral Vasospasm Market with Region Specific Growth and Competitive Analysis on the Basis of Major Players Present in the Market.

Global Cerebral Vasospasm Market - Scenario

The global cerebral vasospasm market is expected to register an approximate CAGR of 5.4% during the forecast period. The narrowing of cerebral arteries is termed as cerebral vasospasm. Cerebral vasospasm is most commonly observed in patients who survive subarachnoid hemorrhage. Narrowing of cerebral artery leads to cerebral ischemia and then death. Increasing prevalence of subarachnoid hemorrhage and a rise in the prevalence of traumatic brain injury is the key factor driving the growth of the market. According to the Centers for Disease Control and Prevention 2017, 30% of the total injury deaths are due to traumatic brain injury in the US. Other factors contributing to the growth of the market are increasing hypertension among the population, rising adoption of smoking, changing lifestyle, growing geriatric population, increasing prevalence of bleeding disorders, rising use of blood thinners and the introduction of technologically advanced treatments.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1418

However, factors such as high cost associated with treatment, risks associated with drugs and medication and a shortage of skilled professionals are expected to hinder the market growth during the forecast period.

Global cerebral vasospasm market is expected to grow at the CAGR of 5.4% during the forecasted period 2017-2023.

Segmentation

Global cerebral vasospasm market is segmented on the basis of type of treatment which includes triple-H therapy, nimodipine and other. On the basis of route of administration the market is segmented into oral, intravenous and intra-arterial and on the basis of end user the market is again segmented into hospitals, clinics and others.

Key Players

Some of the key players in this market are Headsense Medical Ltd (Israel), B. Braun Melsungen AG (Germany), Minnetronix, Inc (US), Bristol-Myers Squibb Company (US), Boehringer Ingelheim GmbH (Germany) and H. Lundbeck A/S (Denmark)

Regional Analysis

The cerebral vasospasm market is dominated by North America owing to the increasing number of traumatic brain injuries in this region. According to the Centers for Disease Control and Prevention, the Traumatic Brain Injury-related Emergency Department visits increased by 47% from 2007 to 2013. Such high incidences of brain traumatic injuries influence market growth. Furthermore, increased adoption of technologically advanced medical implants and the growing healthcare expenditure contribute to enhance the market growth in this region.

It is estimated that Europe was the second largest in the global cerebral vasospasm market. Rising health burden due to smoking drives the market in this region. According to the NHS Digital report on Statistics on Smoking, England, 2018, 484,700 people were hospitalized due to health issues relating to smoking in 2017. This provides favorable backgrounds for the market to grow in this region.

The cerebral vasospasm market in Asia-Pacific is likely to witness growth owing to the increasing number of elderly people. Brain aneurysms develop after the age of 40 years and are commonly observed in the elderly population. According to the Asian Development Bank (ADB), Asia’s geriatric population is expected to reach 923 million by 2050. This contributes to the positive market growth in this region.

The Middle East and Africa holds the least share in the global cerebral vasospasm market due to the presence of stringent government policies and poor economies. However, growing government initiatives, increasing private players investments, and well-equipped healthcare facilities are likely to enhance the market growth in this region.

Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/cerebral-vasospasm-market-1418

Detailed Table Of Contents

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure:

2 Research Methodology

2.1 Research Process:

2.2 Primary Research

2.3 Secondary Research:

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porters Five Forces Model

4.2 Bargaining Power Of Suppliers

4.3 Bargaining Power Of Buyers

4.4 Threat Of New Entrants

4.5 Threat Of Substitutes

4.6 Intensity Of Rivalry

5 Global Cerebral Vasospasm Market, By Type Of Treatment

5.1 Triple-H Therapy

5.2 Nimodipine

5.3 Other

TOC Continued…!

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/1418

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.